ArsenalBio Secures $325M with Regeneron, BMS Backing
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
- Latest
- Trending
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
A new report advises regulators to work with crypto firms to combat threats in the casino sector, including North Korean ...
Explore how cyber insurance policies can help businesses mitigate risks and costs.
Learn strategies to train employees against AI-enhanced cyber threats and boost organizational security effectively.
Bank of America forecasts gold prices hitting $3,000 per ounce in 2025, driven by interest rates and central bank activity.
AI tools like ChatGPT and JetPack enhance learning as schools adopt specialized apps for courses.
Explore cyber resilience to ensure business continuity and bounce forward amidst inevitable cyber threats and attacks.
Attackers spoof Palo Alto VPNs, spreading WikiLoader via SEO poisoning, impacting US and Italian sectors.
HealthEquity surpasses Q2 estimates, increases revenue forecast, and announces share buyback program.
BitGo CEO Mike Belshe addresses criticisms of the Wrapped Bitcoin deal with BiT Global, emphasizing security and transparency.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.